 |
市场调查报告书
商品编码
1529920
危急性肢体缺血治疗市场：依药物、给药途径、最终用户及地区Critical Limb Ischemia Treatment Market, By Drugs, By Route of administration, By End User, By Geography |
||||||
价格
简介目录
预计2024年全球危急性肢体缺血治疗市场规模为51亿美元，预计2031年将达91.1亿美元，2024年至2031年复合年增长率为8.6%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2024年市场规模 | 51亿美元 |
| 实际资料 | 2018-2021 | 预测期 | 2024-2031 |
| 2024-2031 年预测期复合年增长率 | 8.60% | 2031 年金额预测 | 91.1亿美元 |
图：2024 年按地区分類的危急性肢体缺血治疗市场占有率(%)
全球危急性肢体缺血治疗市场是指四肢（例如脚部）血液循环显着减少的医疗状况。这是一种严重的疾病，如果不及时治疗，可能会导致截肢。这种情况是由于脂肪物质在动脉内积聚而引起的，从而导致动脉硬化。血流受到限制，导致四肢剧烈疼痛和溃疡且无法癒合。由于老年人口的增加、周边动脉疾病病例的增加以及对可用治疗方案的认识不断提高，全球危急性肢体缺血治疗市场预计将在未来几年显着增长。
市场动态：
全球危急性肢体缺血治疗市场是由糖尿病（CLI 的主要危险因子）盛行率上升以及全球老年人口不断增加所推动的。此外，用于开发先进治疗设备和药物的研究经费的增加也推动了市场的成长。然而，血管成形术和血管手术的高昂费用阻碍了患者获得治疗。已开发国家对 CLI 的认识不断提高以及报销计划的可用性提供了一个有利可图的机会。
本研究的主要特点
- 该报告对全球危急性肢体缺血治疗市场进行了详细分析，包括以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。 。
- 它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
- 根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球危急性肢体缺血治疗市场的主要企业进行了分析。
- 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
- 全球危急性肢体缺血治疗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 透过用于全球危急性肢体缺血治疗市场分析的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- 一致的机会地图 (COM)
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球危急性肢体缺血治疗市场 - 冠状病毒（COVID-19）大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球危急性肢体缺血治疗市场，依药物划分，2019-2031（十亿美元）
- 介绍
- 抗高血压药
- 抗血小板药物
- 抗血栓剂
- 降血脂剂
- 其他的
第六章 全球危急性肢体缺血治疗市场，依给药途径，2019-2031 年（十亿美元）
- 介绍
- 口服
- 母亲与孩子之间
第七章 全球危急性肢体缺血治疗市场，依最终用户划分，2019-2031 年（十亿美元）
- 介绍
- 医院
- 专科诊所
- 门诊手术中心
- 老人安养院
- 其他的
第八章全球危急性肢体缺血治疗市场，按地区，2019-2031（十亿美元）
- 介绍
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
第9章 竞争格局
- 公司简介
- Advanced Brain Monitoring, Inc.
- Medtronic plc
- fic Corporation
- Abbott Laboratories
- Cook Medical Inc.
- Cardiovascular Systems, Inc.
- Philips Healthcare
- B. Braun Melsungen AG
- Terumo Corporation
- Biotronik SE &Co. KG
- Cordis Corporation
- Smith &Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi SA
- AstraZeneca plc
- Bristol-Myers Squibb Company
第10章分析师建议
- 上升和下降
- 综合机会图
第十一章 参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI7115
The global critical limb ischemia treatment market is estimated to be valued at USD 5.10 Bn in 2024 and is expected to reach USD 9.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2024: | US$ 5.10 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2024 to 2031 CAGR: | 8.60% | 2031 Value Projection: | US$ 9.11 Bn |
Figure. Critical Limb Ischemia Treatment Market Share (%), By Region 2024
Global critical limb ischemia treatment market refers to the medical condition where the blood circulation to extremities like legs is severely reduced. This is a serious condition that can lead to amputation if left untreated. The condition arises due to the accumulation of fatty substances in arteries leading to atherosclerosis. The limited blood flow leads to severe pain and sores on extremities which do not heal. The global critical limb ischemia treatment market is poised to grow significantly in the coming years due to increasing geriatric population, rising cases of peripheral artery diseases, and growing awareness regarding available treatment options.
Market Dynamics:
The global critical limb ischemia treatment market is driven by the rising prevalence of diabetes and growing geriatric population globally which are major risk factors for CLI. Additionally, increasing research funding for the development of advanced treatment devices and drugs is also boosting the market growth. However, high cost of angioplasty and vascular surgeries hampers patient's accessibility to treatment. Growing awareness about CLI and availability of reimbursement coverage in developed nations provides lucrative opportunities.
Key Features of the Study:
- This report provides in-depth analysis of the global critical limb ischemia treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global critical limb ischemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic, Boston Scientific, Cardinal Health, Terumo, Abbott Laboratories, etc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global critical limb ischemia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global critical limb ischemia treatment market
Detailed Segmentation-
- By Drugs
- Antihypertensive Agents
- Antiplatelet Drugs
- Antithrombotic Agents
- Lipid-lowering Agents
- Others
- By Route of administration
- Oral
- Parentral
- Others
- By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Nursing Homes
- Others (Rehabilitation Centers, etc.)
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cook Medical Inc.
- Cardiovascular Systems, Inc.
- Philips Healthcare
- Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drugs
- Market Snapshot, By Route of Administration
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Critical Limb Ischemia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Critical Limb Ischemia Treatment Market, By Drugs, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Antihypertensive Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antiplatelet Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antithrombotic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lipid-lowering Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Critical Limb Ischemia Treatment Market, By Route of Administration 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parentral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Critical Limb Ischemia Treatment Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nursing Homes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Critical Limb Ischemia Treatment Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Advanced Brain Monitoring, Inc.
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic plc
- Boston Scienti Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- fic Corporation
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cook Medical Inc.
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardiovascular Systems, Inc.
- Company Highlights
- Drugs Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Philips Healthcare
- B. Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company
- Advanced Brain Monitoring, Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
